Bladder cancer: how we used a common cold virus to defeat it
Hardev Pandha, University of Surrey Non-muscle invasive bladder cancer is the tenth most common cancer…
Browsing: Latest News
Dosing regimen for an old cancer drug shows new promise as an immunotherapy
By Bendta Schroeder, Massachusetts Institute of Technology As cancer cells progress, they accumulate hundreds and…
New research gives hope in the fight against pancreatic cancer
Mariano Barbacid, Centro Nacional de Investigaciones Oncológicas CNIO Pancreatic ductal adenocarcinoma (PDAC), the most common…
Body fat distribution linked to higher risk of aggressive prostate cancer
In the first prospective study of directly measured body fat distribution and prostate cancer risk,…
Renegade fat cells induce bone-damaging lesions in multiple myeloma
A study of samples from patients with multiple myeloma (MM) has demonstrated how “reprogrammed” fat…
Population DNA testing for disease risk is coming. Here are five things to know
Screening millions of healthy people for their risk of disease can be cost-effective. But it…
Colorectal cancer incidence on the rise among young adults in several high-income countries
The incidence of colon and rectal cancer in adults younger than 50 years has increased…
Strawberry tree honey inhibits cell proliferation in colon cancer lines
Spanish and Italian researchers have proven that when honey from strawberry trees, a product typical…
Proton therapy for cancer lowers risk of side effects
Proton therapy results in fewer side effects than traditional X-ray radiation therapy for many cancer…
New drug effective in overcoming ibrutinib resistance in mantle cell lymphoma
A study at The University of Texas MD Anderson Cancer Center demonstrated how a small…